TrialJournal of psychopharmacology (Oxford, England)2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.
Matthew W Johnson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
382 papers cite itlatest 60 shown
this paperpooled ittrialcites it